Back
Rocket Pharmaceuticals 10K Form
Sell
48
RCKT
Rocket Pharmaceuticals
Last Price:
22.56
Seasonality Move:
12.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCKT News And Ratings
See the #1 stock for the next 7 days that we like better than RCKT
RCKT Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-33.99M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.46 |
| Price / Book: | 4.14 |
Profitability
| EPS (TTM): | -2.94000 |
|---|---|
| Net Income (TTM): | $-245.6M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Rocket Pharmaceuticals Earnings Forecast
Key Rocket Pharmaceuticals Financial Ratios
- The Interest Expense is -0.76% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 6 years.
Rocket Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RCKT |
| CUSIP: | 77313F |
| Website: | rocketpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RCKT Technical Analysis vs Fundamental Analysis
Sell
48
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Sell
The current Rocket Pharmaceuticals [RCKT] share price is $22.52. The Score for RCKT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.